Aliments préemballés : n’achetez pas de riz (suremballé)

Biocoop et l’achat responsable, 2014

A travers sa campagne 2014 de data-telling, Biocoop poursuivit son discours de sensibilisation sur la portée de l’acte d’achat. Les visuels présentent des produits de consommation courante et montrent les effets néfastes sur la planète et pour notre santé.

Launch of the European Human Biomonitoring Initiative

The HBM4EU consortium included lead partners from each of the participating countries, as well as the EEA

A conference to launch the “European Human Biomonitoring Initiative” (HBM4EU) took place on 8 December 2016 in Brussels. It was followed by a half-day stakeholders meeting on 9 December.

HBM4EU is a joint effort of 26 countries and the European Commission, co-funded by Horizon 2020, to coordinate and advance human biomonitoring (HBM) activities in Europe. The stated aim is “to provide better evidence in support of policy making”.

The launch event introduced the initiative and presented some of the key activities to be undertaken. Long-standing HBM activities from programmes outside the European Union, including US, Canada and Japan, were be presented to give participants a perspective on how the EU project fits into the international landscape.

Launch of EU human biomonitoring initiative, env-health, 8 December 2016.

Although 26 countries are involved, biomonitoring will take place in 25 countries, including 22 EU members and three non-members. They are Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Finland, Germany, Greece, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom. Information on the national organisations participating in the consortium can be found here.

The nine substance groupings that will be the focus of the European Human Biomonitoring Initiative in the first two years (2017-2018) are:

  • phthalates and Hexamoll® DINCH,
  • bisphenols,
  • per-/polyfluorinated compounds,
  • flame retardants,
  • cadmium and chromium,
  • PAHs,
  • aniline family,
  • chemical mixtures,
  • and emerging substances.

A half-day technical consultation took place the following day. It will be the first in a series of more in-depth discussions with stakeholders that accompanies annual work plans. Génon Jensen, HEAL Executive Director spoke at the introductory session on the project and its stakeholder process on: “Human biomonitoring to inform and empower citizens”. This main session was followed by break-out groups on research and stakeholder expectations.

HEAL has become the informal coordinator on human biomonitoring for NGOs working on chemicals because of our long involvement in promoting human biomonitoring for better health and environmental policy. In 2006, HEAL undertook a small-scale biomonitoring programme on mercury, which resulted in health moving to the centre of international discussions on mercury.

More Information

  • The role of human biomonitoring in assessing and managing chemical risks, eea.europa.eu.
  • The initial prioritisation exercise and selected substances, eea.europa.eu.

Produits de beauté dangereux

Perturbateurs endocriniens dans les produits cosmétiques et d’hygiène corporelle

Toxic Lake : The Untold Story of Lake Okeechobee

An investigation by The Weather Channel featuring Kait Parker, 2016

“Toxic Lake” is the latest endeavor by The Weather Channel to explore the intersection of weather, the environment and social justice.

The Weather Channel’s digital team, led by correspondent Kait Parker, takes a closer look at the history of Lake Okeechobee and the future implications of this toxic algae pollution.

Over the last two decades, the environmental crisis of Florida’s Lake Okeechobee has continued to worsen and dominate local headlines. The lake is the nation’s second largest freshwater lake, but due to years of missteps, it’s been producing massive amounts of toxic algae that have closed beaches, destroyed businesses and poisoned swimmers.

  • Toxic Lake” is hosted by Weather Channel meteorologist Kait Parker. The article, was written by Pulitzer Prize-winning reporter Marcus Stern.
  • Watch this pesticides video playlist on YouTube.

Produits chimiques et cheveux

Etes-vous pollué(e) de perturbateurs endocriniens?

La gestion des perturbateurs endocriniens, vu par Gros.

High genetic correlations found between six psychiatric disorders

Personality Traits and Psychiatric Disorders Linked to Specific Genomic Locations

A meta-analysis of genome-wide association studies (GWAS) has identified six loci or regions of the human genome that are significantly linked to personality traits, report researchers at University of California San Diego School of Medicine in this week’s advance online publication of Nature Genetics. The findings also show correlations with six psychiatric disorders.

Abstract

Personality is influenced by genetic and environmental factors1 and associated with mental health. However, the underlying genetic determinants are largely unknown.

We identified six genetic loci, including five novel loci2, 3, significantly associated with personality traits in a meta-analysis of genome-wide association studies (N = 123,132–260,861). Of these genome-wide significant loci, extraversion was associated with variants in WSCD2 and near PCDH15, and neuroticism with variants on chromosome 8p23.1 and in L3MBTL2. We performed a principal component analysis to extract major dimensions underlying genetic variations among five personality traits and six psychiatric disorders (N = 5,422–18,759).

Some genetic variants linked to extraversion and neuroticism personality traits have been identified.

The first genetic dimension separated personality traits and psychiatric disorders, except that neuroticism and openness to experience were clustered with the disorders. High genetic correlations were found between extraversion and attention-deficit–hyperactivity disorder (ADHD) and between openness and schizophrenia and bipolar disorder. The second genetic dimension was closely aligned with extraversion–introversion and grouped neuroticism with internalizing psychopathology (e.g., depression or anxiety).

In addition, there were high genetic correlations between extraversion and attention deficit hyperactivity disorder (ADHD) and between openness and schizophrenia and bipolar disorder. Neuroticism was genetically correlated with internalized psychopathologies, such as depression and anxiety.

Study and Press Release

Adult ADHD

Illness inflation – How everyday conditions become medical disorders

Drugs for treatment of adult ADHD carry risk of dependence, abuse.

. A persistent condition?
. Questionable diagnosis
. A surprising death
. Little research on benefits vs. harm
. A move to the mainstream

– Read Drugs for treatment of adult ADHD carry risk of dependence, by Journal Sentinel‘s special report: Illness inflation, How everyday conditions become medical disorders.
– Enjoy our health infographics album on Flickr.

New method to diagnose ASD children for anxiety symptoms shown to be effective

Anxiety Disorders Interview Schedule–Autism Addendum: Reliability and Validity in Children With Autism Spectrum Disorder

In children on the spectrum, anxiety is often masked by the symptoms of autism. But a new variant to a standard anxiety screening method has now proven effective in separating the two and it is leading to important diagnoses.

Abstract

Assessing anxiety in autism spectrum disorder (ASD) is inherently challenging due to overlapping (e.g., social avoidance) and ambiguous symptoms (e.g., fears of change).

An ASD addendum to the Anxiety Disorders Interview Schedule–Child/Parent, Parent Version (ADIS/ASA) was developed to provide a systematic approach for differentiating traditional anxiety disorders from symptoms of ASD and more ambiguous, ASD-related anxiety symptoms.

Interrater reliability and convergent and discriminant validity were examined in a sample of 69 youth with ASD (8–13 years, 75% male, IQ = 68–143) seeking treatment for anxiety. The parents of participants completed the ADIS/ASA and a battery of behavioral measures. A second rater independently observed and scored recordings of the original interviews.

Treating anxiety is important in autism spectrum disorder because anxiety is associated with significantly more impairment for the child and their family.

Findings suggest reliable measurement of comorbid (intraclass correlation = 0.85–0.98, κ = 0.67–0.91) as well as ambiguous anxiety-like symptoms (intraclass correlation = 0.87–95, κ = 0.77–0.90) in children with ASD. Convergent and discriminant validity were supported for the traditional anxiety symptoms on the ADIS/ASA, whereas convergent and discriminant validity were partially supported for the ambiguous anxiety-like symptoms. Results provide evidence for the reliability and validity of the ADIS/ASA as a measure of traditional anxiety categories in youth with ASD, with partial support for the validity of the ambiguous anxiety-like categories. Unlike other measures, the ADIS/ASA differentiates comorbid anxiety disorders from overlapping and ambiguous anxiety-like symptoms in ASD, allowing for more precise measurement and clinical conceptualization. Ambiguous anxiety-like symptoms appear phenomenologically distinct from comorbid anxiety disorders and may reflect either symptoms of ASD or a novel variant of anxiety in ASD.

Study and Press Release
  • Anxiety Disorders Interview Schedule–Autism Addendum: Reliability and Validity in Children With Autism Spectrum Disorder, Journal of Clinical Child & Adolescent Psychology, doi/full/10.1080/15374416.2016.1233501, 07 December 2016.
  • Anxiety measure for children with autism proven reliable, Drexel University, December 8, 2016.

Low Testosterone

Illness inflation – How everyday conditions become medical disorders

Millions may have ‘low testosterone. But critics say it is just about getting older and fatter.

Independent experts say the new definition is an example of ‘medicalization’ – turning common evolution into medical conditions that call for treatment.

Finding good online resources for mental health support

Search engines ‘could help young people find best mental health resources’

Search engines and content providers could have a role to play in helping young people find the most reliable mental health resources online.

With well over 10,000 apps in the mental health area, quantity is not the problem. It’s much more about understanding people’s lives and how they communicate and, of course, it’s about quality.

AyeMind aims to create a digital platform to support young people in mental wellbeing and create digital resources for it; and DocReady is designed to help with a person’s first GP conversation on mental health.